ArticleACS environmental Au2026
Discrepancy between Occupational Exposure Levels and Health Risks Limits the Health Benefits of a Concentration-Oriented VOC Regulation Strategy.
Article in ACS environmental Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Industrial volatile organic compounds (VOCs) are strictly controlled worldwide. However, the gap between VOC regulation and health effects has increased owing to the complexity of characterizing deleterious species and understanding their hazards. By identifying the differences in exposure patterns among VOC-related industries, we examined occupational exposure profiles in 24 industries by analyzing 557 samples collected in breathing zones. The high-end exposure level was used to estimate aggregate health risk, and the cumulative risks for affected organs/tissues were then assessed individually by using the dose addition and response addition method. The results revealed an obvious discrepancy between the exposure level and health risk in complicated industrial settings. Low VOC exposure might significantly threaten health, whereas high exposure might have only a slight effect on health, suggesting a transition of the VOC regulation strategy from total concentration reduction to risk reduction. High-level exposure to acrolein, 1,2-dichloropropane, 1,2-dibromoethane, formaldehyde, and methyl methacrylate poses the highest risk to the respiratory system. We further developed an understanding that total VOC concentration reductions do not bring an equal proportion of health benefits in most industries. These conclusions highlight the importance of considering both health and atmospheric chemistry in determining VOC limits and promoting industrial sustainability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.